Search Results
Jul 31, 2026, 04:03 ET e& vermeldet im ersten Halbjahr 2026 einen Anstieg des Konzernumsatzes um 11,6 % auf 38,1 Mrd. AED
H1 2026H1 2025
More news about: e&
Jul 31, 2026, 02:10 ET Pearson Interim Results for the six months to 30th June 2026 (Unaudited)
movements. First half adjusted profit margin increased 140bps to 15.5% (H1 2025: 14.1%).Adjusted net finance costs increased to £35m (H1 2025: £24m). The effective tax rate on adjusted profit before tax increased to 25.8% (H1 2025: 24.5%) due to a one-off tax charge arising on the settlement of
More news about: Pearson
Jul 31, 2026, 02:10 ET Pearson Interim Results for the six months to 30th June 2026 (Unaudited)
movements. First half adjusted profit margin increased 140bps to 15.5% (H1 2025: 14.1%).Adjusted net finance costs increased to £35m (H1 2025: £24m). The effective tax rate on adjusted profit before tax increased to 25.8% (H1 2025: 24.5%) due to a one-off tax charge arising on the settlement of
More news about: Pearson
Jul 31, 2026, 02:04 ET FIRST AMGEN SCHOLARS PROGRAM IN INDIA LAUNCHES AT IIIT HYDERABAD
www.amgenfoundation.orgAbout IIIT HyderabadThe International Institute of Information Technology, Hyderabad (IIIT-H) is an autonomous research university founded in 1998 that focuses on the core areas of Information Technology, such as Computer Science, Electronics
More news about: Amgen
Jul 30, 2026, 22:00 ET CASA-V 7A 逸爽絲速乾舒爽系列正式上市
108%（遠超標準要求的 ≥80%）及乾燥速率達到 0.34 g/h（顯著優於標準要求的 ≥0.20 g/h）。這種高效的排濕能力，能讓吸收的水分在短時間內向外擴散並快速蒸發，使面料長時間保持輕盈透氣，不會因積汗而變得沈重或暗沈，從而維持外觀的透亮質感與乾淨清爽。*GB/T 21655.1-2023 《紡織品吸濕速乾性的評定第1 部分:單項組合試驗法》結果2. 極緻功能 H型速乾纖維通過特殊工藝布料纖維以H 型滌綸開發，讓截面呈 H 形的異形滌綸纖維，核心優勢在於溝槽帶來的高效吸濕排汗、纖維間空隙提升的蓬鬆保暖與易染性，同時保留滌綸強
More news about: Casablanca
Jul 30, 2026, 19:50 ET U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
Nephrol. 2025;36(8):1614-1625. doi:10.1681/ASN.0000000655. PMID: 40036081; PMCID: PMC12342098. 11 Blackowicz MJ, Falzon L, Beck W, Tran H, Weiner DE. Economic evaluation of expanded hemodialysis with the Theranova 400 dialyzer: A post hoc evaluation of a randomized clinical trial in the
More news about: U.S. Renal Care
Jul 30, 2026, 17:22 ET FUJIFILM GFX100RF: A 102 MP Point-and-Shoot Medium Format Camera; YouTube Video at B&H
tour of the B&H Photo SuperStore, located at 420 Ninth Avenue. The techno-carousel spins all year round at the counters and kiosks at B&H. With hundreds of products on display, the B&H Photo SuperStore is the place to test-drive and compare all the latest gear.The B&H
More news about: B&H Photo
Jul 30, 2026, 17:07 ET Beauty Creations llega a CVS Pharmacy, lo que supone su mayor hito hasta la fecha en el sector minorista
obtenido varios premios y reconocimientos del sector que ponen de manifiesto su continuo impulso. La presencia comercial de la marca ya abarca la cadena H-E-B y mercados internacionales en más de 47 países, y tiene previstas nuevas inversiones en nuevas categorías de productos y colaboraciones a medida que
More news about: Beauty Creations Cosmetics
Jul 30, 2026, 16:30 ET Corteva Delivers Strong 1H 2026, Raises FY 2026 Outlook, On-Track for October 1 Separation
Seed 1H results reflect continued value capture on latest in-demand germplasm and trait technologies, including licensing growthCrop Protection 1H demand for new products and focus on operational excellence helped offset competitive pricing dynamicsFull-year 2026
More news about: Corteva Agriscience
Jul 30, 2026, 16:15 ET Erie Indemnity Reports Second Quarter 2026 Results
1H'261H'25
More news about: Erie Indemnity Company
Jul 30, 2026, 16:05 ET Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
0.03Provision for income taxes (h)0.01
More news about: Illumina, Inc.
Jul 30, 2026, 16:05 ET Farmer Mac Reports Second Quarter 2026 Results
121,327Series H, par value $25 per share, 4,000,000 shares authorized, issued and outstanding
More news about: Farmer Mac
Jul 30, 2026, 16:01 ET PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
demonstrated dose-dependent disease slowing on cUHDRS scale in Stage 2 participants, reaching 52% at 10 mg dose levelPlan to engage with FDA in 2H 2026 to discuss PIVOT-HD 24-month results being finalizedINVEST-HD study being conducted and funded by partner Novartis with target enrollment
More news about: PTC Therapeutics, Inc.
Jul 30, 2026, 14:52 ET TeacherLists Helps School Communities Get First-Day-Ready
child's classroom-specific lists. TeacherLists partners with major and regional retailers, including Walmart, Target, Amazon, Staples, Office Depot, H-E-B, Meijer, Dollar General, Kroger, and CVS to offer shopping online, in-store, or both, giving families options to shop the way that works for them.School
More news about: TeacherLists
Jul 30, 2026, 13:54 ET Friends of PAHO Leads Call from Health, Security, and Business Leaders for Continued U.S. Leadership in the Pan American Health Organization
fever, smallpox, polio, malaria and more.The past few years have demonstrated that the U.S. remains vulnerable to infectious disease threats: H5N1 Avian Influenza, Dengue, Chagas, chikungunya and leishmaniasis are now in the United States, and New World Screwworm has reemerged after it was eliminated
More news about: Friends of PAHO
Jul 30, 2026, 13:07 ET POSITIVE STELLUNGNAHME DES CHMP UNTERSTÜTZT BREITERE ANWENDUNG VON AMGENS REPATHA® VOR ERSTEM HERZINFARKT ODER SCHLAGANFALL
Naturkautschuk (einem Latexderivat), der allergische Reaktionen hervorrufen kann. Natriumgehalt: Repatha enthält weniger als 1 mmol Natrium (23 mg) pro Dosis, d. h., es ist im Wesentlichen „natriumfrei".Wechselwirkungen: Für Repatha wurden keine formellen Studien zu Wechselwirkungen mit anderen Arzneimitteln
More news about: Amgen
Jul 30, 2026, 12:45 ET AVIS FAVORABLE DU CMUH CONCERNANT UNE UTILISATION PLUS LARGE DE REPATHA® D'AMGEN POUR REDUIRE LES RISQUES DE PREMIER INFARCTUS DU MYOCARDE OU D'AVC
https://doi.org/10.1161/cir.0000000000001303. MAC : REF-107092Le, H. et al. (2025). Very High Prevalence of Nonoptimally Controlled Traditional Risk Factors at the Onset of Cardiovascular Disease. JACC, Volume 86 (Number
More news about: Amgen
Jul 30, 2026, 11:53 ET Expert insights on diabetes care, space diagnostics, Alzheimer's and Down syndrome linkages, and advances in cancer screening draw nearly 17,000 attendees to ADLM 2026
registered for ADLM 2026. More attendees are expected today, the last day of the meeting.In the opening plenary, Dr. David M. Nathan, the 2026 Wallace H. Coulter Lectureship awardee, shared valuable lessons he learned over five decades leading U.S. diabetes research, emphasizing the necessity of robust
More news about: Association for Diagnostics & Laboratory Medicine (ADLM)
Jul 30, 2026, 11:45 ET Universal Music Group N.V. Reports Financial Results for the Second Quarter and Half Year Ended June 30, 2026
artist and product costs, increased by €281 million to €3,622 million in H1 2026. Cost of revenues as a percentage of revenue increased to 58.5% in H1 2026 from 56.8% in H1 2025. Excluding Downtown, cost of revenues was 57.1% of sales in H1 2026, driven by higher product costs.Artist
More news about: Universal Music Group N.V.
Jul 30, 2026, 11:45 ET Universal Music Group N.V. Reports Financial Results for the Second Quarter and Half Year Ended June 30, 2026
in H1 2026. Cost of revenues as a percentage of revenue increased to 58.5% in H1 2026 from 56.8% in H1 2025. Excluding Downtown, cost of revenues was 57.1% of sales in H1 2026, driven by higher product costs.Artist costs increased to €3,045 million, or 49.2% of sales in H1 2026
More news about: Universal Music Group N.V.
Jul 30, 2026, 11:00 ET Balance Point Announces its Investment in ShipSigma
www.invernessgraham.com Adam H. SauerteigOffice: [email protected]
More news about: Balance Point Capital
Jul 30, 2026, 10:31 ET Piramal Pharma Limited annonce ses résultats pour le T1 2027
résultatsPiramal Pharma Limited organisera une téléconférence destinée aux investisseurs et analystes le 30 juillet 2026, de 9h30 à 10h15 (IST), afin de présenter ses résultats du premier trimestre de l'exercice 2027.Informations pour suivre la téléconférence :
More news about: Piramal Pharma Limited
Jul 30, 2026, 10:30 ET Aarti Industries Delivers Promising Q1 FY27; Reaffirms Long-Term Growth Outlook
track for commissioning and ramp-up in Q2 FY27, while execution of the Re Aarti chemical recycling project is progressing as planned for commissioning in H2 FY27.Capacity Expansion: Successfully completed the Fuel Additives capacity expansion from 290 KTPA to 360 KTPA in July 2026, strengthening
More news about: Aarti Industries Limited
Jul 30, 2026, 10:07 ET PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors Should Contact SueWallSt
"it took us years to build a patch pump product at scale with quality, high yield, safety" during the February 2025 earnings call.Flavia H. Pease — EVP and CFO (September 30, 2025 to present). Pease signed quarterly and annual SEC filings containing allegedly misleading statements
More news about: SueWallSt.com
Jul 30, 2026, 09:25 ET POZITÍVNE STANOVISKO VÝBORU PRE LIEKY NA HUMÁNNE POUŽITIE PODPORUJE ŠIRŠIE POUŽÍVANIE LIEKU REPATHA® OD SPOLOČNOSTI AMGEN PRED PRVÝM INFARKTOM ALEBO MOZGOVOU PRÍHODOU
https://doi.org/10.1161/cir.0000000000001303. MAC adresa: REF-107092Le, H. a kol. (2025). Veľmi vysoká prevalencia neoptimálne kontrolovaných tradičných rizikových faktorov na začiatku kardiovaskulárneho ochorenia. JACC, ročník 86
More news about: Amgen